Arcoma AB (ARCOMA) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.001x

Based on the latest financial reports, Arcoma AB (ARCOMA) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr68.00K ≈ $7.32K USD) by net assets (Skr75.54 Million ≈ $8.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ARCOMA market cap for the company's overall valuation and market capitalisation.

Arcoma AB - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Arcoma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Arcoma AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arcoma AB ranked by their cash flow conversion efficiency. Explore ARCOMA cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Holista Colltech Ltd AU:HCT	-0.382x
Sarama Resource V:SWA	0.426x
G.M. LEATHER S.P.A. F:N78	N/A
Kingsrose Mining Ltd AU:KRM	-0.189x
Stavely Minerals Ltd AU:SVY	-0.422x
Prospera Energy Inc V:PEI	-0.250x
Asturiana de Laminados S.A. MC:ELZ	0.921x
Buxton Resources Ltd AU:BUX	-0.863x

Annual Cash Flow Conversion Efficiency for Arcoma AB (2012–2025)

The table below shows the annual cash flow conversion efficiency of Arcoma AB from 2012 to 2025. View latest Arcoma AB stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr74.73 Million ≈ $8.04 Million	Skr18.72 Million ≈ $2.01 Million	0.251x	-21.13%
2024-12-31	Skr59.33 Million ≈ $6.39 Million	Skr18.84 Million ≈ $2.03 Million	0.318x	-19.34%
2023-12-31	Skr48.66 Million ≈ $5.24 Million	Skr19.16 Million ≈ $2.06 Million	0.394x	+10191.91%
2022-12-31	Skr45.88 Million ≈ $4.94 Million	Skr-179.00K ≈ $-19.26K	-0.004x	+91.11%
2021-12-31	Skr44.04 Million ≈ $4.74 Million	Skr-1.93 Million ≈ $-207.91K	-0.044x	-131.74%
2020-12-31	Skr49.53 Million ≈ $5.33 Million	Skr6.85 Million ≈ $736.74K	0.138x	-43.73%
2019-12-31	Skr45.19 Million ≈ $4.86 Million	Skr11.10 Million ≈ $1.19 Million	0.246x	+21208.34%
2018-12-31	Skr39.03 Million ≈ $4.20 Million	Skr45.00K ≈ $4.84K	0.001x	+100.53%
2017-12-31	Skr40.83 Million ≈ $4.39 Million	Skr-8.91 Million ≈ $-958.86K	-0.218x	-74.65%
2016-12-31	Skr37.35 Million ≈ $4.02 Million	Skr-4.67 Million ≈ $-502.14K	-0.125x	-26.04%
2015-12-31	Skr49.92 Million ≈ $5.37 Million	Skr-4.95 Million ≈ $-532.48K	-0.099x	-399.55%
2014-12-31	Skr41.73 Million ≈ $4.49 Million	Skr-828.00K ≈ $-89.11K	-0.020x	+97.90%
2013-12-31	Skr12.52 Million ≈ $1.35 Million	Skr-11.82 Million ≈ $-1.27 Million	-0.944x	-122.06%
2012-12-31	Skr24.14 Million ≈ $2.60 Million	Skr-10.27 Million ≈ $-1.10 Million	-0.425x	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$11.70 Million

Skr108.74 Million SEK

Market Cap Rank

#26754 Global

#568 in Sweden

Share Price

Skr7.60

Change (1 day)

-4.52%

52-Week Range

Skr6.92 - Skr9.80

All Time High

Skr25.60